1. Wang, Xingguo, Li, Yongfeng, Qu, Liang, Ma, Meng, Wang, Kehua. 2020. Lipolytic gene DAGLA is targeted by miR-223 in chicken hepatocytes. In Gene, 767, 145184. doi:10.1016/j.gene.2020.145184. https://pubmed.ncbi.nlm.nih.gov/32998047/
2. Yan, Yu-Chuan, Meng, Guang-Xiao, Yang, Chun-Cheng, Dong, Zhao-Ru, Li, Tao. 2023. Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity. In Cell death & disease, 14, 404. doi:10.1038/s41419-023-05919-5. https://pubmed.ncbi.nlm.nih.gov/37414748/
3. Bainbridge, Matthew N, Mazumder, Aloran, Ogasawara, Daisuke, Torkamani, Ali, Friedman, Jennifer. . Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome. In Brain : a journal of neurology, 145, 3383-3390. doi:10.1093/brain/awac223. https://pubmed.ncbi.nlm.nih.gov/35737950/
4. Ishiguro, Hiroki, Higuchi, Susumu, Arinami, Tadao, Onaivi, Emmanuel S. 2017. Association between alcoholism and the gene encoding the endocannabinoid synthesizing enzyme diacylglycerol lipase alpha in the Japanese population. In Alcohol (Fayetteville, N.Y.), 68, 59-62. doi:10.1016/j.alcohol.2017.09.005. https://pubmed.ncbi.nlm.nih.gov/29477030/
5. Kim, Helena K, Gonçalves, Vanessa F, Husain, Muhammad I, Zai, Gwyneth, Kloiber, Stefan. 2023. Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia. In Psychiatry research, 330, 115563. doi:10.1016/j.psychres.2023.115563. https://pubmed.ncbi.nlm.nih.gov/37924773/
6. Kim, Helena K, Zai, Gwyneth, Müller, Daniel J, Tripathy, Shreejoy J, Kloiber, Stefan. 2022. Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study. In Pharmacopsychiatry, 55, 297-303. doi:10.1055/a-1872-0844. https://pubmed.ncbi.nlm.nih.gov/35793696/
智鼠故事 
